EFTA01522090.pdf
👁 1
💬 0
📄 Extracted Text (139 words)
GHISLAINE MAXWELL- OAP FDG ACCT.
For the Period 10/1/II to loaini
Equity Summary
Beginning Ending Change Current
Asset Categories Market Value Market Value In Value Allocation
US Large Cap Equity 145,237 97 156 591 73 11,353.76 98%
Current
Market Value/Cost Penod Value
Market Value 156,591.73
Tax Cost 147,157.52
Unrealized Gain/Loss 9,434.21
Estimated Annual Income 5,389.64
Accrued Dividends 527.15
Yield 3.44%
Equity Detail
Adjusted Tax Cost Unrealized Est. Annual Inc
Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield
US Large Cap Equity
ABBOTT LABORATORIES 53.87 148.000 7,972.78 7,308.74 664.02 284.16 3 56%
002824-10-0 ABT 71.04
AIR PRODUCTS & CHEMICALS INC 86.14 86.030 7,408.04 7,148.42 259.62 199.52 2.69%
009158-10.6 APD 49.88
AUTOMATIC DATA PROCESSING INC 52.33 150.000 7,849.50 7.264.05 585.45 216.00 2.75%
053015-10-3 ADP
JP Morgan Page 4 of 10
Confidential Treatment Requested by JPMorgan JPM-SDNY-00049569
Chase
CONFIDENTIAL SDNY_GM_00318767
EFTA01522090
ℹ️ Document Details
SHA-256
318b94b77d266df1d9b4ebc07ad89d084b6c7fea7673774f98f9c72f13802cb3
Bates Number
EFTA01522090
Dataset
DataSet-10
Type
document
Pages
1
💬 Comments 0